| The diarylquinoline TMC207 for multidrug-resistant tuberculosis AH Diacon, A Pym, M Grobusch, R Patientia, R Rustomjee, L Page-Shipp, ... New England Journal of Medicine 360 (23), 2397-2405, 2009 | 1089 | 2009 |
| The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study W Hoefsloot, J Van Ingen, C Andrejak, K Ängeby, R Bauriaud, P Bemer, ... European Respiratory Journal 42 (6), 1604-1613, 2013 | 929 | 2013 |
| The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ... The lancet Respiratory medicine 5 (4), 291-360, 2017 | 752 | 2017 |
| HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response SSA Karim, GJ Churchyard, QA Karim, SD Lawn the Lancet 374 (9693), 921-933, 2009 | 725 | 2009 |
| Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment EL Corbett, B Marston, GJ Churchyard, KM De Cock The Lancet 367 (9514), 926-937, 2006 | 653 | 2006 |
| Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of … H Getahun, W Kittikraisak, CM Heilig, EL Corbett, H Ayles, KP Cain, ... PLoS medicine 8 (1), e1000391, 2011 | 538 | 2011 |
| High-dose rifapentine with moxifloxacin for pulmonary tuberculosis A Jindani, TS Harrison, AJ Nunn, PPJ Phillips, GJ Churchyard, ... New England Journal of Medicine 371 (17), 1599-1608, 2014 | 513 | 2014 |
| Achieving the health Millennium Development Goals for South Africa: challenges and priorities M Chopra, JE Lawn, D Sanders, P Barron, SSA Karim, D Bradshaw, ... The Lancet 374 (9694), 1023-1031, 2009 | 475 | 2009 |
| Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study GE Gray, M Allen, Z Moodie, G Churchyard, LG Bekker, M Nchabeleng, ... The Lancet infectious diseases 11 (7), 507-515, 2011 | 456 | 2011 |
| What we know about tuberculosis transmission: an overview G Churchyard, P Kim, NS Shah, R Rustomjee, N Gandhi, B Mathema, ... The Journal of infectious diseases 216 (suppl_6), S629-S635, 2017 | 453 | 2017 |
| Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment E Hnizdo, T Singh, G Churchyard Thorax 55 (1), 32-38, 2000 | 433 | 2000 |
| High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ... The Lancet infectious diseases 17 (1), 39-49, 2017 | 408 | 2017 |
| Building a tuberculosis-free world: The Lancet Commission on tuberculosis MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ... The Lancet 393 (10178), 1331-1384, 2019 | 382 | 2019 |
| Epidemiology of HIV-associated tuberculosis SD Lawn, G Churchyard Current Opinion in HIV and AIDS 4 (4), 325-333, 2009 | 342 | 2009 |
| Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare … EL Corbett, T Bandason, T Duong, E Dauya, B Makamure, GJ Churchyard, ... The Lancet 376 (9748), 1244-1253, 2010 | 325 | 2010 |
| Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers RS Wallis, M Maeurer, P Mwaba, J Chakaya, R Rustomjee, GB Migliori, ... The Lancet infectious diseases 16 (4), e34-e46, 2016 | 320 | 2016 |
| Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection JD Simmons, CM Stein, C Seshadri, M Campo, G Alter, S Fortune, ... Nature Reviews Immunology 18 (9), 575-589, 2018 | 311 | 2018 |
| A trial of mass isoniazid preventive therapy for tuberculosis control GJ Churchyard, KL Fielding, JJ Lewis, L Coetzee, EL Corbett, ... New England Journal of Medicine 370 (4), 301-310, 2014 | 295 | 2014 |
| Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa P Mee, KL Fielding, S Charalambous, GJ Churchyard, AD Grant Aids 22 (15), 1971-1977, 2008 | 291 | 2008 |
| Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners EL Corbett, S Charalambous, VM Moloi, K Fielding, AD Grant, C Dye, ... American journal of respiratory and critical care medicine 170 (6), 673-679, 2004 | 275 | 2004 |
